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1004-47 A Randomized Comparison of Transradial and 
Transfemoral Approaches for Coronary Angiography 
and Percutaneous Transluminal Coronary Angioplasty 
in Octogenarians: Final Results of the OCTO-PLUS 
Study
Yves Louvard, Rémi Sabatier, Hakim Benamer, Philippe Garot, David Hildick-Smith, 
Christophe Loubeyre, Thierry Lefèvre, Gilles Grollier, Martial Hamon, Institut 
Cardiovasculaire Paris Sud, Massy, France
Background: The rate of access site complications after coronary angiography (Angio)
and/or PCI has been shown to be higher in older patients. This prospective randomized
study was carried out to assess the potential advantages of Transradial (TRA) approach
in this setting.
Methods: Patients (pts) undergoing Angio or PCI were randomized to either transfemoral
approach (TFA) or TRA in 5 centers using TRA in routine. The primary end-point was the
rate of access site complications leading to increased hospital stay.
Results: Study population included 371 pts, mean age 82.8 + 2.9 years, 53.4 % male,
presenting with unstable angina in 35.6% of cases or AMI in 10.5%. 188 pts were ran-
domized to TRA (174 angio followed by 87 PCI, and 9 PCI), 183 to TFA (176 angio fol-
lowed by 74 PCI and 12 PCI). 51.9% of PCI pts received a femoral closure device. Main
results by intention to treat are summarized below: 
* per protocol: 0.5% vs 7.6%, p= 0.001
Conclusion: Combined end-point of all approach-related vascular complications leading
to prolonged hospital stay is significantly lower in octogenarians randomized to transra-
dial approach for coronary angiography and/or PCI compared to transfemoral approach.
As in younger patients, for coronary angiography, X-Ray exposure time is slightly but sig-
nificantly longer in the transradial group. There is no difference in X-Ray exposure time
for PCI, procedural time, contrast medium volume and equipment use in Angio and PCI.
1004-48 Randomized Trial of Radial Versus Femoral Access for 
Primary and Rescue Angioplasty
Warren J. Cantor, Geoff Puley, Madhu Natarajan, Vlad Dzavik, Mina Madan, Anne Fry, 
Nurry Pirani, Hahn Hoe Kim, James Velianou, Bradley H. Strauss, Robert J. Chisholm, 
St. Michael's Hospital, Toronto, ON, Canada
Background: Transradial access for percutaneous coronary intervention (PCI) results in
fewer bleeding and vascular complications, earlier ambulation and improved patient com-
fort. Limited data exists for radial access in acute myocardial infarction (MI), where reper-
fusion must occur quickly.
Methods: In a multicentre pilot trial, 50 patients with MI requiring either primary or res-
cue PCI were randomized to radial or femoral access. Patients in cardiogenic shock were
excluded. All patients received aspirin and heparin. All operators had previously per-
formed at least 100 transradial cases. Procedure times were prospectively measured. All
patients underwent ultrasound-Doppler of the access site, and were followed to 30 days.
Results: To date, procedural data, inhospital events and Doppler results are available for
44 patients (25 radial, 19 femoral). Thrombolysis was used in 68% of cases and glyco-
protein IIb/IIIa inhibitors were used in 91%. Crossover from radial to femoral access was
required in one case. PCI was performed in 41 patients, with stenting in 39. One proce-
dural failure occurred in the radial group due to inability to cross the occlusion. The time
from local anaesthesia to first balloon inflation was 32 (26, 38) min for radial and 25 (22,
30) min for femoral access (p=0.04). There were no significant differences in contrast use
or fluoroscopy time. No patients required intra-aortic balloon pump. No patients experi-
enced major bleeding or required transfusions. By Doppler there were two asymptomatic
radial occlusions and two pseudoaneurysms (one in each group). There were no strokes,
reinfarctions, vascular surgeries, bypass or repeat PCI. One patient in the femoral group
died two days after PCI. Outcomes at 30 days and quality of life data will be presented.
Conclusions: Transradial access for primary or rescue PCI is feasible with high success
rates similar to femoral access. Although radial access was associated with a longer time
to reperfusion, the difference was small and likely not clinically significant. In patients
without shock, major bleeding and vascular complications are infrequent with either
access site despite the high use of thrombolysis and GP IIb/IIIa inhibitors.
1004-49 The Risk of Bleeding in Renal Failure Patients 
Undergoing Glycoprotein IIb/IIIa Receptor Inhibition: A 
Report From the American College of Cardiology-
National Cardiovascular Data Registry
Hursh S. Naik, Peter Y. M. Hui, Rupsa R. Yee, Richard E. Shaw, American College of 
Cardiology National Cardiovascular Data Registry (ACC-NCDR), Bethesda, MD
Background: Renal dysfunction is present in a substantial number of patients undergo-
ing percutaneous coronary intervention (PCI). Few studies have investigated the effect of
Glycoprotein (Gp) IIb/IIIa inhibition in these patients. The purpose of this study was to
evaluate bleeding complications with Gp IIb/IIIa inhibitors in patients with renal failure.
Methods: Between January 1, 2001 and March 31, 2003 data from 278,105 consecutive
PCI procedures were submitted from 304 institutions to the American College of Cardiol-
ogy National Cardiovascular Data Registry (ACC-NCDR). Vascular bleeding events with
and without IIb/IIIa inhibitors were compared in patients with renal dysfunction using chi-
square analysis.
Results: Out of 278,105 patients in the ACC-NCDR registry, 12,059 patients had renal
failure. Renal failure was defined as a documented history of renal failure that was
treated with medication, low protein diet, or dialysis by a physician. In the absence of Gp
IIb/IIIa inhibition, patients with renal failure had more bleeding complications than those
without renal failure (2.8% vs. 1.9% p-value <0.0001). However, in the renal failure group
there was no significant increase in bleeding complications with or without the addition of
Gp IIb/IIIa inhibitors (2.4% vs. 2.8% p-value = ns).
Conclusion: The presence of renal dysfunction during PCI predisposes patients to
bleeding complications. This risk is not significantly increased with the addition of Gp IIb/
IIIa inhibitors. Therefore, Gp IIb/IIIa inhibition in the setting of renal dysfunction, does not
appear to be an independent risk factor for bleeding.
1004-50 Percutaneous Ulnar Artery Approach for Coronary 
Diagnostic and Therapeutic Interventions
Eduardo Aptecar, Patrick Dupouy, Mourad Chabane-Chaouch, Youssef Elhajj, Jean-Marc 
Pernès, Clinique Les Fontaines, Melun, France, Hôpital Privé d'Antony, Antony, France
Background: While the transradial approach is now a well established alternative to fem-
oral approach, the use of the ulnar artery has rarely been intended for percutaneous cor-
onary interventions (PCI).
Aim of the study: to ascertain the feasability and security of the transulnar approach for
PCI.
Methods: 143 consecutive patients referred for PCI were screened, and were eligible if a
good ulnar pulse was present and if the Allen test was positive. The right ulnar artery was
punctured with a 20-gauge x 2” entry needle, into which a straight 0.025” guide wire was
inserted (Radifocus Introducer II, Terumo). A 4 F introducer was placed on the wire.
Sodium heparin (3,000 IU) and verapamil (2.5 mg) were injected. Coronary arteries and
left ventricle were catheterized with 4 F JL4 and JR4 or AL2, and pig-tail catheters.
Angioplasty was made using 5 or 6 F guiding catheters. Manual compression was done
after retrieval of the introducer. An Echo Doppler of the wrist vessels was done 10 + 7
days after procedure.
Results: from 143 patients screened, ulnar access was intended in 107 pts (73%), suc-
cessful in 96 pts (91%). Time and number of ponctions were 118 ± 135 sec and 1,6
(maximal 5). 
There were no procedural complications. Echo Doppler was obtained in 91 pts (94%).
Access site complications were: 0 occlusion, 1 pseudo-anevrysm, 3 slight hematomas.
Conclusion : ulnar artery approach is a feasible and safe alternative to radial approach
for percutaneous coronary interventions.
1004-51 Assessment of the Feasibility, Safety, and Success of 
Transradial Access for Percutaneous Coronary 
Intervention: A Report From the American College of 
Cardiology-National Cardiovascular Data Registry
Ahmed S. Ahmed, Mohammed Murtaza, Timothy Catchings, Richard Webel, Ba Lin, 
Richard Shaw, Greg C. Flaker, University of Missouri-Columbia, Columbia, MO, The 
American College of Cardiology, Bethesda, MD
Background: Previous studies have shown that transradial access (TRA) appears to be
safe, with an acceptable success rate, but these studies were limited by small sample
size. The purpose of this study was to evaluate the feasibility, safety and success rate of
the TRA for percutaneous coronary intervention (PCI) in contemporary practice. Meth-
ods: Between January 1, 2001 and March 31, 2003, data on 278,105 PCI procedures
were submitted from 304 institutions to the American College of Cardiology National Car-
diovascular Data Registry (ACC-NCDR). Of these, valid data on access site entry were
available for 275,290 PCI procedures. TRA was used in 3,237 (1.2%) of these proce-
Radial P value Femoral
Cross-over (%) 9.0 ns 8.2
Angio duration (min 18.5±10.5 0.069 16.4±11.0
X-ray duration (min) 6.0±4.4 0.01 4.4±3.4
PCI success (%) 95.3 ns 93.7
PCI duration (min) 33.9±21.6 ns 34.1±23.1
PCI X-ray duration (min) 11.5±9.5 ns 10.8±9.9
Primary endpoint* 1.6 0.03 6.6
Hematoma>3 cm (%) 2.2 0.0025 11.4
Procedures Number Success 
rate
Procedural 
time
X-ray time X-ray dose
% (min) (min) (Gycm2)
Coronarography 71 100 13,2 + 5,2 7,1 + 3,5 35 + 27
Coronarography + 
PTCA
20 100 41+ 26 19,4 + 14 126 + 70
DelayedPTCA 5 100 25 + 16 13 + 7 74 + 38
